tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

TNF Pharmaceuticals to study TNF-alpha in patients taking GLP-1s
The FlyTNF Pharmaceuticals to study TNF-alpha in patients taking GLP-1s
4d ago
NVO
TNFA
Novo Nordisk announces FDA approval of Ozempic for kidney disease risk
PremiumThe Fly
Novo Nordisk announces FDA approval of Ozempic for kidney disease risk
5d ago
NVO
Contact Levi & Korsinsky LLP by March 25, 2025 Deadline to Join Class Action Against Novo Nordisk A/S(NVO)
PremiumClass Action
Contact Levi & Korsinsky LLP by March 25, 2025 Deadline to Join Class Action Against Novo Nordisk A/S(NVO)
9d ago
NVO
Novo Nordisk criticized for not disclosing payments to health groups, STAT says
PremiumThe Fly
Novo Nordisk criticized for not disclosing payments to health groups, STAT says
9d ago
NVO
Unusually active option classes on open January 24th
PremiumThe Fly
Unusually active option classes on open January 24th
9d ago
MA
NU
Morning Movers: American Express and Verizon trend higher following Q4 results
PremiumThe FlyMorning Movers: American Express and Verizon trend higher following Q4 results
9d ago
BA
VZ
Novo Nordisk amycretin data helps rebut concerns, says BofA
Premium
The Fly
Novo Nordisk amycretin data helps rebut concerns, says BofA
9d ago
NVO
Novo Nordisk shares jump on phase 1b/2a subcutaneous amycretin trial results
Premium
The Fly
Novo Nordisk shares jump on phase 1b/2a subcutaneous amycretin trial results
9d ago
NVO
Sector Spotlight: Big Pharma will push to pause Medicare drug price negotiations
PremiumThe Fly
Sector Spotlight: Big Pharma will push to pause Medicare drug price negotiations
16d ago
ABT
BMY
Supreme Court upholds TikTok ban, Ozempic selected for price talks: Morning Buzz
PremiumThe Fly
Supreme Court upholds TikTok ban, Ozempic selected for price talks: Morning Buzz
16d ago
T
CRM
JPMorgan says Novo’s Ozempic, Rybelsus inclusion in price negotiations expected
PremiumThe Fly
JPMorgan says Novo’s Ozempic, Rybelsus inclusion in price negotiations expected
16d ago
NVO
Novo Nordisk high dose weight loss data ‘a double edged sword,’ says BofA
PremiumThe Fly
Novo Nordisk high dose weight loss data ‘a double edged sword,’ says BofA
16d ago
NVO
Novo Nordisk data boosts H.C. Wainwright confidence in Viking’s potential
PremiumThe FlyNovo Nordisk data boosts H.C. Wainwright confidence in Viking’s potential
16d ago
NVO
VKTX
Novo Nordisk price target lowered to $110 from $140 at Argus
Premium
The Fly
Novo Nordisk price target lowered to $110 from $140 at Argus
16d ago
LLY
NVO
Novo Nordisk drops after Ozempic selected for U.S. price negotiations
Premium
The Fly
Novo Nordisk drops after Ozempic selected for U.S. price negotiations
16d ago
NVO
Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
PremiumThe Fly
Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
16d ago
AZN
BHC
Novo Nordisk’s Semaglutide 7.2mg s.c. achieved 21% weight loss in STEP UP trial
PremiumThe Fly
Novo Nordisk’s Semaglutide 7.2mg s.c. achieved 21% weight loss in STEP UP trial
16d ago
NVO
Novo Nordisk price target raised to DKK 798 from DKK 795 at Guggenheim
PremiumThe Fly
Novo Nordisk price target raised to DKK 798 from DKK 795 at Guggenheim
16d ago
NVO
Insulin prices have dropped but some poor patients are paying more, NYT says
PremiumThe Fly
Insulin prices have dropped but some poor patients are paying more, NYT says
17d ago
LLY
NVO
Drugmakers to push Trump to pause price negotiations, Bloomberg reports
PremiumThe FlyDrugmakers to push Trump to pause price negotiations, Bloomberg reports
19d ago
AZN
BMY
Novo Nordisk price target lowered to DKK 900 from DKK 1,000 at Deutsche Bank
Premium
The Fly
Novo Nordisk price target lowered to DKK 900 from DKK 1,000 at Deutsche Bank
23d ago
NVO
Novo Nordisk, Valo Health expand drug discovery collaboration
Premium
The Fly
Novo Nordisk, Valo Health expand drug discovery collaboration
25d ago
NVO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >